ALCON INC ALC

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $74.24
Market Cap $35.86B
P/E Ratio 37.49
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑4.9% YoY
$10.32B
3-Yr CAGR: 6.0%
Net Income ↓-100.0% YoY
$980.00M
Net Margin: 0.0%
Free Cash Flow ↑7.7% YoY
$1.73B
FCF Yield: 4.82%
EPS (Diluted) ↓-3.4% YoY
$1.98
Basic: $1.99
Return on Equity Efficiency
4.4%
ROA: 3.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ALC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2009
FY 2010 $7,179.0M $2,475.0M $2,475.0M $2,375.0M $2,066.0M
FY 2017 $6,785.0M -5.5% $3,204.0M $-127.0M -105.1% $0.52 $1,218.0M $803.0M -61.1%
FY 2018 $7,153.0M +5.4% $3,192.0M $-300.0M -136.2% $-0.46 -188.5% $1,140.0M $616.0M -23.3%
FY 2019 $7,508.0M +5.0% $3,662.0M $-332.0M -10.7% $-1.34 -191.3% $920.0M $367.0M -40.4%
FY 2020 $6,833.0M -9.0% $2,940.0M $-635.0M -91.3% $-1.09 +18.7% $823.0M $344.0M -6.3%
FY 2021 $8,291.0M +21.3% $4,652.0M $418.0M +165.8% $0.76 +169.7% $1,345.0M $645.0M +87.5%
FY 2022 $8,654.0M +4.4% $4,748.0M $463.0M +10.8% $0.68 -10.5% $1,217.0M $581.0M -9.9%
FY 2023 $9,370.0M +8.3% $5,247.0M $832.0M +79.7% $1.96 +188.2% $1,388.0M $730.0M +25.6%
FY 2024 $9,836.0M +5.0% $5,512.0M $1,256.0M +51.0% $2.05 +4.6% $2,077.0M $1,604.0M +119.7%
FY 2025 $10,319.0M +4.9% $5,745.0M -100.0% $1.98 -3.4% $2,271.0M $1,728.0M +7.7%
$

Valuation

Market Price $74.24
Market Cap $35.86B
Enterprise Value $35.27B
P/E Ratio 37.49
P/B Ratio 1.64
FCF Yield 4.82%
Dividend Yield N/A
Shares Outstanding 487,700,000
%

Profitability & Margins

Gross Margin 55.67%
Operating Margin 13.18%
Net Margin 0.00%
Return on Equity (ROE) 4.45%
Return on Assets (ROA) 3.11%
Asset Turnover 0.33x
Revenue 3-Yr CAGR 6.04%
🛡️

Financial Health & Liquidity

Current Ratio 0.11
Cash Ratio 8.39
Debt / Equity 0.043
Debt / Assets 0.030
Cash & Equivalents $1.53B
Total Debt $938.00M
Book Value / Share $45.18
💧

Cash Flow Efficiency

Operating Cash Flow $2.27B
Capital Expenditures (CapEx) $543.00M
Free Cash Flow $1.73B
OCF / Revenue 22.01%
FCF / Revenue 16.75%
FCF 3-Yr CAGR 43.81%
🏷️

Per Share Metrics

EPS (Diluted) $1.98
EPS (Basic) $1.99
Dividends / Share N/A
Book Value / Share $45.18
EPS YoY Growth -3.41%
🏛️

Balance Sheet (FY 2025)

Total Assets $31.55B
Total Liabilities $9.52B
Stockholders' Equity $22.04B
Current Assets $20.00M
Current Liabilities $182.00M